Thomas Meds – 609075 – 08/26/2020

DATE: August 26, 2020 WARNING LETTER The United States (U.S.) Food and Drug Administration (FDA) has determined that Thomas Meds offers products for sale in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). More specifically, your network...

MCM-Related Guidance

Image FDA develops guidance to provide its policy perspectives and recommendations on a wide variety of topics. The guidance documents below may be of special interest to existing or prospective medical countermeasure (MCM) sponsors, and other stakeholders, including...

Invitrx Therapeutics Inc. – 581182

Delivery Method: VIA UNITED PARCEL SERVICE Product: Biologics Recipient: Recipient Name Habib (nmi) Torfi Recipient Title Chief Executive Officer Invitrx Therapeutics Inc. 20503 Crescent Bay DriveLake Forest, CA 92630United States Issuing Office: Center for Biologics...

Abington Memorial Hospital, IRC – 576854

Reference #: CBER-19-02 Product: Biologics Recipient: Recipient Name G. Chris Christensen III Abington Memorial Hospital, IRC 1200 Old York RoadAbington, PA 19001United States Issuing Office: Center for Biologics Evaluation and Research 10903 New Hampshire AvenueWO 71...